Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Milestone Scientific, a provider of technological solutions for the medical and dental markets, has acquired additional patent rights with respect to painless anesthetic injections - specifically rights related to controlling the flow rate or pressures used in providing these injections - through issuance of 260,000 shares of restricted common stock.
Subscribe to our email newsletter
In connection with this acquisition, Milestone has also agreed to terminate its declaratory judgment action against Milton Hodosh related to claimed infringements of his patent rights and Dr Hodosh has agreed to terminate his existing infringement action against the company. Each party is responsible for their own attorney fees.
Joe Martin, CEO of Milestone, said: “We are pleased to have acquired these additional patent rights, which strengthen our position as the dominant leader of advanced technology for administering painless anesthetic injections without expending any of our cash resources. Also, the related settlement of our declaratory judgment action against Dr Hodosh and his infringement action against us eliminates further legal expense.”